Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

International expansion of Celgene's Thalomid accelerated through recent agreements

Nov. 21, 2001

Inhibitors of P-450RAI as an approach to psoriasis and other retinoid-responsive disorders

Nov. 20, 2001

E.U. approval of Protopic recommended by CPMP

Nov. 20, 2001

Interim results show OrCel's efficacy and speed in healing diabetic ulcers

Nov. 19, 2001

Novel compounds described in recent patent as chemokine IL-8 antagonists

Nov. 9, 2001

Chemokine IL-8 receptor antagonists claimed by GSK scientists

Nov. 8, 2001

Positive phase IV results reported for Olux in mild to moderate body psoriasis

Nov. 8, 2001

Positive preliminary data obtained for frozen OrCel in Rx of venous leg ulcers

Nov. 8, 2001

New chemokine IL-8 receptor antagonists under study at GSK

Nov. 2, 2001

Tissue engineering product to begin clinical trials in the U.S.

Oct. 26, 2001

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...